Patch 1999.

Methods	Randomised: Yes, but method not described. Concealment: method not described. Double‐blind: Yes. Description of withdrawals/dropouts: no. Length of FU: 42 days Jadad score: 3/5.
Participants	Country: U.K. Diagnosis of bleeding: unknown. Source of bleeding: unknown. Endoscopy: unknown. Diagnosis of cirrhosis: unknown. 133 patients Child's C = 62% Alcoholic cirrhosis = unknown.
Interventions	Terlipressin versus placebo. Rx: terlipressin 2 mg iv every four hours for 48 h then 1mg iv every 4 h for 72 h. Control: placebo. Time from admission to treatment: unknown. Initial sclerotherapy: unknown.
Outcomes	1. Mortality at 42 days. 2. Failure of initial haemostasis at five days. 3. Rebleeding: NR. 4. Procedures required for haemostasis: NR. 5. Blood transfusions. 6. LOS: NR.
Notes	Source of funding: unknown. Published in abstract only yet.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear